ARTICLE | Clinical News
Remimazolam: Phase III started
December 14, 2015 8:00 AM UTC
Paion began a double-blind, U.S. Phase III trial to compare IV remimazolam vs. placebo and open-label midazolam in about 75 high-risk patients undergoing a colonoscopy. Patients will receive 2.5-5 mg ...